Clinical trial
Epiceram Versus Elidel for Treatment of Mild to Moderate Atopic Dermatitis
NCT00460083 · Ceragenix Pharmaceuticals, Industry · Completed
Key facts
| NCT number | NCT00460083 |
|---|---|
| Title | Epiceram Versus Elidel for Treatment of Mild to Moderate Atopic Dermatitis |
| Official title | A Randomized, Double-Blinded Study of Epiceram Versus Elidel in Pediatric Subjects With Mild to Moderate Atopic Dermatitis |
| Lead sponsor | Ceragenix Pharmaceuticals, Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Atopic Dermatitis |
| Intervention type | Device, Drug |
| Interventions | Elidel(R) (pimecrolimus 1%), EpiCeram(R) -ceramide based barrier repair cream |
| Enrollment | 35 |
| Start date | Apr 1, 2007 |
| Primary completion | Dec 1, 2007 |
| Completion | Feb 1, 2008 |
| First posted | Apr 13, 2007 |
| Last update posted | Feb 6, 2008 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- 1–9 Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: